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Abstract: Mosquitoes are vectors of arboviruses affecting animal and human health. Arboviruses
circulate primarily within an enzootic cycle and recurrent spillovers contribute to the emergence
of human-adapted viruses able to initiate an urban cycle involving anthropophilic mosquitoes.
The increasing volume of travel and trade offers multiple opportunities for arbovirus introduction in
new regions. This scenario has been exemplified recently with the Zika pandemic. To incriminate
a mosquito as vector of a pathogen, several criteria are required such as the detection of natural
infections in mosquitoes. In this study, we used a high-throughput chip based on the BioMark™
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Dynamic arrays system capable of detecting 64 arboviruses in a single experiment. A total of
17,958 mosquitoes collected in Zika-endemic/epidemic countries (Brazil, French Guiana, Guadeloupe,
Suriname, Senegal, and Cambodia) were analyzed. Here we show that this new tool can detect
endemic and epidemic viruses in different mosquito species in an epidemic context. Thus, this
fast and low-cost method can be suggested as a novel epidemiological surveillance tool to identify
circulating arboviruses.
Keywords: mosquito-borne viruses; molecular epidemiology; surveillance; microfluidic analysis
1. Introduction
The World Health Organization stated in February 2016 that Zika infection was considered as a
public health emergency of international concern [1] opening a new chapter in the history of vector-borne
diseases. Arboviruses are viruses transmitted among vertebrate hosts by arthropod vectors. Successful
transmission of an arbovirus relies on a complex life cycle in the vector, which after midgut infection and
dissemination, is released in saliva for active transmission to the vertebrate host [2]. Arboviruses belong
to nine families: Asfarviridae, Flaviviridae, Orthomyxoviridae, Reoviridae, Rhabdoviridae, the newly
recognized Nyamiviridae (order Mononegavirales), and the families Nairoviridae, Phenuiviridae, and
Peribunyaviridae in the new order, Bunyavirales. Most arboviruses possess an RNA genome and
are mainly transmitted by mosquitoes [3]. While acute infections in vertebrate hosts are typically
self-limiting, arboviruses establish persistent infections in arthropods granting a central role as a viral
reservoir to the vector [4].
Arboviruses circulate primarily within an enzootic cycle involving zoophilic vector species and
non-human hosts. Recurrent spillovers cause occasional infections of humans initiating an epidemic
cycle. Arboviruses such as dengue (DENV; Flavivirus, Flaviviridae), chikungunya (CHIKV; Alphavirus,
Togaviridae), Zika (ZIKV; Flavivirus, Flaviviridae), and Yellow fever virus (YFV; Flavivirus, Flaviviridae)
do not need to amplify in wild animals to cause outbreaks in humans, which act simultaneously as
amplifier, disseminator, and source of infection for the major vectors, the anthropophilic mosquitoes
Aedes aegypti and Aedes albopictus [5]. Thus, the success of these viruses comes from their feature
to be mainly transmitted by human-biting mosquitoes strongly adapted to urban environments.
The establishment of a new epidemic cycle is undoubtedly related to the introduction of a viremic
vertebrate host (humans, animals) acting as a vehicle for importation of the virus into environments
receptive to viral amplification. Other arboviruses such as West Nile virus (WNV; Flavivirus,
Flaviviridae) remain circulating within an enzootic cycle with sporadic spillovers causing human cases.
Many regions experience simultaneous circulation of different arboviruses [6,7], and co-infections
in vectors were reported [8]. These coinfections can present an opportunity for viruses to exchange
genetic material. Impacts of such genetic events on virulence for vertebrate hosts are still unknown [9].
Thus, being able to detect a wide range of arboviruses in thousands of field-collected mosquitoes in a
single experiment can be a valuable tool to predict arboviral emergences in human populations. Indeed,
similar methods were developed with success to screen tick-borne pathogens (bacteria, parasites, and
viruses) and allowed the detection of expected and unexpected pathogens in large-scale epidemiological
studies [10,11]. Therefore, we developed a high-throughput system based on real-time microfluidic
PCR, which is able to detect 96 mosquito-borne viruses in 96 samples within one single run. With this
method, we have screened: (1) Mosquitoes infected artificially using a feeding system to validate our
tool, (2) mosquitoes collected in countries endemic for the major human arboviruses (e.g., Senegal,
Cambodia, Brazil), and (3) mosquitoes collected during the Zika and Yellow fever outbreaks in the
Americas (French Guiana, Guadeloupe, Brazil, Suriname). This method allowed for the detection
of epidemic viruses (ZIKV, CHIKV, YFV) but also unexpected viruses (e.g., Trivittatus virus, TVTV,
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Orthobunyavirus, Bunyaviridae) underlining the need of such a tool for early detection of emerging
mosquito-borne viruses.
2. Materials and Methods
2.1. Mosquitoes
To test the ability of our assays to detect viruses present in pools of mosquitoes, 47 batches of three
infected mosquitoes of the species, Ae. aegypti, Ae. albopictus, and Cx. pipiens (infection performed by
artificial feeding system), were provided by the Institut Pasteur (Paris). Six different viruses, single
or double infections, were tested in a pilot study. Briefly, batches of 60 7–10-day-old females were
challenged with an infectious blood meal containing 1.4 mL of washed rabbit erythrocytes, 700 µL of
viral suspension, and 1 mM of adenosine 5’-triphosphate (ATP) as a phagostimulant [12]. The blood
meal was provided to mosquitoes at a titer of 107 focus-forming unit (FFU)/mL using a Hemotek
membrane feeding system (Hemotek Ltd., Blackburn, UK). After 20 min, fully engorged females were
transferred in cardboard containers and maintained with 10% sucrose until examination.
In ZIKV-endemic and -epidemic regions from South America, Africa, and Asia (Brazil, French
Guiana, Guadeloupe, Suriname, Senegal, Cambodia), adult mosquitoes were collected, identified using
morphological characters, and dissected to separate abdomen from the remaining body parts (RBP)
(See Tables 1–6 for details). Abdomens of the same species were grouped by pools of 20–30 individuals
in cryovials, and RBP were stored individually at −80 ◦C until further analysis.
2.2. RNA Extraction
Total RNAs were extracted from each pool using the Nucleospin RNA II extraction kit
(Macherey-Nagel, Hoerdt, France). Pools were ground in 350 µL Lysis Buffer and 3.5 µL
β-mercaptoethanol using the homogenizer Precellys®24 Dual (Bertin, France) at 5500 rpm for 20 s.
Total RNA per pool was eluted in 50 µL of RNase free water and stored at −80 ◦C until use.
When pools of abdomens were positive for virus, the RBP (head/thorax) of individual mosquitoes
composing each pool were homogenized in 300 µL of DMEM with 10% fetal calf serum using the
homogenizer Precellys®24 Dual (Bertin, France) at 5500 rpm for 20 s. Then, total RNAs were extracted
from 100 µL of homogenates using the Nucleospin RNA II extract kit (Macherey-Nagel, Germany) and
200 µL were conserved at −80 ◦C for attempts to isolate the virus. Total RNA per sample was eluted in
50 µL of RNase free water and stored at −80 ◦C until use.
2.3. Reverse Transcription and cDNA Pre-Amplification
RNAs were transcribed to cDNA by reverse transcription using the qScript cDNA Supermix kit
according to the manufacturer’s instructions (Quanta Biosciences, Beverly, USA). Briefly, the reaction
was performed in a final volume of 5 µL containing 1 µL of qScript cDNA supermix 5X, 1 µL of RNA,
and 3 µL of RNase free water; with one cycle at 25 ◦C for 5 min, one cycle at 42 ◦C for 30 min, and one
final cycle at 85 ◦C for 5 min.
For cDNA pre-amplification, the Perfecta Preamp Supermix (Quanta Biosciences, Beverly, USA)
was used according to the manufacturer’s instructions. All primers were pooled to a final concentration
of 200 nM each. The reaction was performed in a final volume of 5 µL containing 1 µL Perfecta Preamp
5×, 1.25 µL pooled primers, 1.5 µL distilled water, and 1.25 µL cDNA, with one cycle at 95 ◦C for 2 min,
14 cycles at 95 ◦C for 10 s, and 3 min at 60 ◦C. At the end of the cycling program, the reactions were 1:5
diluted. Pre-amplified cDNAs were stored at −20 ◦C until use.
2.4. Assay Design
Mosquito-borne viruses (MBV), their targeted genes, and the corresponding primers/probe sets
are listed in Table S1. For a total of 64 viruses including 149 genotypes/serotypes, primers and probes
were specifically designed. Indeed, selection was based on specific constraints of temperature of
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annealing (60 ◦C for primers and 70 ◦C for probes); primers/probe sets published in the literature were
included if they fit into these criteria. Each primer/probe set was validated using a dilution range
of several cDNA positive controls (when available) (Table S1), by real-time PCR on a LightCycler®
480 (LC480) (Roche Applied Science, Penzberg, Germany). Real-time PCR assays were performed in
a final volume of 12 µL using the LightCycler® 480 Probe Master Mix 1X (Roche Applied Science,
Germany) with primers and probes at 200 nM and 2 µL of control cDNA (virus reference material) or
DNA (Plasmid). Thermal cycling conditions were as follows: 95 ◦C for 5 min, 45 cycles at 95 ◦C for
10 s, and 60 ◦C for 15 s, and one final cooling cycle at 40 ◦C for 10 s.
2.5. High-Throughput Real-Time PCR
The BioMark™ real-time PCR system (Fluidigm, South San Francisco, CA, USA) was used for
high-throughput microfluidic real-time PCR amplification using the 96.96 dynamic arrays (Fluidigm,
South San Francisco, CA, USA). These chips dispensed 96 PCR mixes and 96 samples into individual
wells, after which on-chip microfluidics assembled PCR reactions in individual chambers prior to thermal
cycling resulting in 9216 individual reactions. Real-time PCRs were performed using FAM- and black
hole quencher (BHQ1)-labeled TaqMan probes with TaqMan Gene Expression Master Mix in accordance
with manufacturer’s instructions (Applied Biosystems, Foster City, CA, USA). Thermal cycling conditions
were as follows: 2 min at 50 ◦C, 10 min at 95 ◦C, followed by 40 cycles of 2-step amplification of 15 sec at
95 ◦C, and 1 min at 60 ◦C. Data were acquired on the BioMark™ real-time PCR system and analyzed
using the Fluidigm real-time PCR Analysis software to obtain Ct values (see Michelet et al. 2014 for more
details [10]). Primers and probes were evaluated for their specificity against cDNA reference samples.
One negative water control was included per chip. To determine if factors present in the sample could
inhibit the PCR, Escherichia coli strain EDL933 DNA was added to each sample as an internal inhibition
control, using primers and probes specific for the E. coli eae gene [13].
2.6. Validation of the Results by Real-Time PCR, Virus Isolation, and Genome Sequencing
When cDNA of pools of abdomens were detected positive for viruses, the cDNAs of RBP
(head/thorax) of individual mosquitoes composing each pool were screened by real-time PCRs on a
LightCycler® 480 (LC480) (Roche Applied Science, Penzberg, Germany). Real-time PCR assay targeting
the virus of interest (see primers/probe sets in Table S1) was performed in a final volume of 12 µL
using the LightCycler® 480 Probe Master Mix 1X (Roche Applied Science, Germany), with primers
and probes at 200 nM and 2 µL of control DNA. Thermal cycling conditions were as follows: 95 ◦C for
5 min, 45 cycles at 95 ◦C for 10 s, and 60 ◦C for 15 s, and one final cooling cycle at 40 ◦C for 10 s.
When a positive sample was confirmed, virus isolation was attempted in Vero and C6/36 cells.
Then, total RNA was extracted using the Nucleospin RNA II extract kit (Macherey-Nagel, Hoerdt,
France) following the manufacturer instructions and full genome sequencing was attempted. For ZIKV,
12 overlapping amplicons were produced using the reverse transcriptase Platinum Taq High Fidelity
polymerase enzyme (Thermo Fisher Scientific, Waltham, MA, USA) and specific primers (Table S2).
PCR products were pooled in equimolar proportions. After Qubit quantification using Qubit® dsDNA
HS Assay Kit and Qubit 2.0 fluorometer (Thermo Fisher Scientific, Waltham, MA, USA), amplicons
were fragmented (sonication) into fragments of 200 bp long. Libraries were built adding barcode for
sample identification, and primers to fragmented DNA using AB Library Builder System (Thermo
Fisher Scientific, Waltham, MA, USA). To pool the barcoded samples equimolarly, a quantification
step by the 2100 Bioanalyzer instrument (Agilent Technologies, Santa Clara, California, USA) was
performed. An emulsion PCR of the pools and loading on 520 chip was done using the automated Ion
Chef instrument (Thermo Fisher Scientific, Waltham, MA, USA). Sequencing was performed using the
S5 Ion torrent technology (Thermo Fisher Scientific, Waltham, MA, USA) following manufacturer’s
instructions. Consensus sequence was obtained after removing the 30 first and last nucleotides of each
read, trimming reads depending on quality (reads with quality over >99%) and length (reads over
100 pb were kept), and mapping them on a reference (KY415987, most similar sequence after Blastn)
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using CLC genomics workbench software 11.0.1 (Qiagen, Hilden, Germany). A de novo contig was
also produced to ensure that the consensus sequence was not affected by the reference sequence.
3. Results
One hundred and forty-nine primer/probe sets were designed to detect 64 MBV (Table S1). Among
them, 95 sets of primers/probe specifically identified their corresponding positive control samples
(37 viral RNA) via Taqman RT-real-time PCRs or Taqman real-time PCRs on a LightCycler 480 apparatus.
Resulting Ct values varied from 8 to 42 depending on sample type and nucleic acid concentration.
Unfortunately, 54 designs were not tested due to the lack of RNA positive control.
To avoid sensitivity problems, cDNA pre-amplification was included in the assay. This step
enabled detection of all positive controls (95 primer/probe sets tested on 37 viral RNAs) via Taqman
real-time PCRs on a LC480 apparatus. The specificity of each primers/probe set was then evaluated
using 37 MBV positive controls on the BioMark™ system (Figure 1A,B). Results demonstrated high
specificity for each primer/probe set after pre-amplification (Figure 1A,B). Indeed, 91 assays (among the
149 developed) were only positive for their corresponding positive controls. Four designs demonstrated
cross-reactivity with a virus from the same species or genus: DENV-1 assay amplified also DENV-2,
DENV-2 assay cross-reacted with DENV-3 and DENV-4, DENV-4 cross-reacted with DENV-3, and one
WNV assay amplified Usutu virus (USUV). Specificity of 54 assays was not fully tested in the absence
of their respective positive controls. Nevertheless, those designs did not show any cross-reaction with
RNA positive controls from other viruses.
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throughput technique developed. The system was able to identify the six viruses present in different 
mosquitoes (Figure 2). Indeed, seven batches were infected by DENV-1, four by DENV-3, four by 
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Figure 1. BioMark™ dynamic array system specificity test (96.96 chip). Specificity of primers/probe
sets from the Table S1 are presented in two figures, (A,B). Fifty-one sets of primers/probe targeting
viruses are presented in (A) and 94 sets in (B), some of them are present into both figures. Each square
corresponds to a single real-ti e PCR reaction, where rows indicate the pathog n in the positive control
and columns represe t the targets of each primer/probe et. Ct values for ach reac ion are indicated in
color; the corresponding color scale is presented in the legend on the right. The darkest shade of blue
and black squares are considered as negative reactions with Ct > 30. chik: Chikungunya; deng: Dengue;
EnM: Murray Encephalitis; St Louis Enc: Saint Louis Encephalitis; EEE: Eastern Equine Encephalitis;
WEE: Western Equine Encephalitis; VEE: Venezuelan Equine Encephalitis; JE: Japanese Encephalitis;
YF: Yellow fever; Kok: Kokobera group; Maya: Mayaro; ONN: O’nyong nyong; RVF: Rift Valley Fever;
Seml: Semliki forest; Spond: Spondweni; Tahy: Tahyna; WN: West Nile; Wess: Wesselsbron; Kout:
Koutango; Guama: Guama Group; Calif Enc: California Encephalitis; GpC: C Group; Key: Keystone;
Snow: Snowshoe hare.
3.1. Laboratory-Infected Mosquitoes
Forty-seven batches each containing three infected mosquitoes were screened with the
high-throughput technique developed. The system was able to identify the six viruses present
in different mosquitoes (Figure 2). Indeed, seven batches were infected by DENV-1, four by
DENV-3, four by DENV-4, 3 by CHIKV, five by WNV, 13 batches by ZIKV, and 10 batches were
coinfected by CHIKV and DENV-2. As for the specificity test, DENV-1, DENV-2, and DENV-3 assays
demonstrated cross-reactions.
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Figure 2. Screening of artificially infected mosquitoes through the BioMark™ dynamic array system
developed (96.96 chip). Each square corresponds to a single real-time PCR reaction, where rows
indicate the batches of mosquitoes tested and columns represent the targets of each primer/probe
set. Crosses indicate cross-reaction of assays. Ct values for each reaction are indicated in color; the
corresponding color scale is presented in the legend on the right. The darkest shade of blue and black
squares are considered as negative reactions with Ct > 30. chik: Chikungunya; deng: Dengue; En :
urray Encephalitis; St Louis Enc: Saint Louis Encephalitis; EEE: Eastern Equine Encephalitis virus;
EE: estern Equine Encephalitis; EE: enezuelan Equine Encephalitis; JE: Japanese Encephalitis;
F: Yello fever; Kok: Kokobera grou; Maya: Mayaro; ONN: O’nyong nyong; RVF: Rift Valley
Fever; Seml: Semliki fores; Spond: Spondweni; Tahy: Tahyna; WN: West Nile; ess: Wesselsbron;
o t: Koutango.
3.2. Field-Collected osquitoes fro Ende ic and Epide ic Areas
total of 17,958 field-collected mosquitoes in six countries from the African, American, and Asian
continents were screened for arbovirus.
3.3. Endemic Areas
3.3.1. Senegal
In Senegal, 934 arthropods including 6 sandflies and 928 mosquitoes (25 males and 909 females)
from 21 species and five genera (detailed in Table 1), were collected in the Kedougou area (Southeastern
Senegal) from August to November 2017. Moreover, 402 larvae were also collected in the same
area from August 2017 to January 2018 and reared until adult emergence in insectarium (188 males
and 214 females obtained). Mosquitoes were grouped by species and sex; 231 and 112 pools were
respectively analyzed for MBVs. YFV was detected in one pool of 20 females of Aedes furcifer and
was confirmed in head/thorax from 1 Aedes furcifer female by RT-real-time PCR. Virus isolation was
attempted but without any success.
3.3.2. Cambodia
In Cambodia, 492 mosquitoes (73 males and 419 females) from 28 species and 5 genera (detailed
in Table 2), were collected in one area at two periods, the dry season in May 2019 and the rainy season
in November 2018. Mosquitoes were grouped by species and sex into 109 pools and were analyzed for
MBVs. No virus was detected (Table 2).
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Table 1. Mosquito and sandflies species, number of mosquitoes collected, and number of pools analyzed in Senegal.
Stage
Collected
Collection
SITE GPS Coordinates
Urban Rural
Sylvatic Mosquito Species
Number of
Arthropods
Screened
Virus Detected
through
Microfluidic
System
Type of
Confirmation
Performed
Adult
Baraboye 12◦41′11.2” N/12◦24′39.2” W Rural
Ae. furcifer, Ae. dalzieli, Ae. taylori,
Ae. vittatus, An. coustani, An.
funestus, Ma. uniformis, sandflies
97 - -
Ngari 12◦38′07.3” N/12◦14′59.5” W Rural
Ae. furcifer, Ae. dalzieli, Ae. aegypti,
Ae. argenteopunctatus, Ae. hirsutus,
Ae. mcintoshi, Cx. quinquefasciatus,
Ae. vittatus, An. coustani, An.
funestus,
96 - -
Silling 12◦32′36.5” N/12◦16′18.7” W Rural Ae. luteocephalus, An. gambiae 3 - -
Tenkoto 12◦40′23.1” N/12◦16′37.1” W Rural Ae. furcifer 5 - -
Velingara 12◦27′33.9” N/12◦03′17.3” W Rural
Ae. aegypti, Ae. dalzieli, Ae. furcifer,
Ae. luteocephalus, Ae. vittatus, An.
coustani
43 - -
Kedougou
(C1F) 12
◦39′42.1” N/12◦16′05.2” W Sylvatic
Ae. aegypti, Ae. furcifer, Ae.
luteocephalus, Ae. taylori, Ae.
unilineatus, Ae. vittatus, An.
coustani, An. funestus, An. nili, Cx.
perfuscus, Ma. africana, Ma.
uniformis
151 - -
Kedougou
(D1F) 12
◦36′43.9” N/12◦14′50.7” W Sylvatic
Ae. aegypti, Ae. africanus, Ae. dalzieli,
Ae. furcifer, Ae. luteocephalus, Ae.
taylori, Ae. unilineatus, Ae. vittatus,
An. coustani, An. funestus, An. nili,
Cx. annulioris, Cx. bitaeniorhynchus,
Cx. poicilipes, Cx. perfuscus, Ma.
africana, Ma. uniformis
278 YFV * Literature
Kedougou
(E2F) 12
◦29′21.2” N/12◦06′06.2” W Sylvatic
Ae. aegypti, Ae. africanus, Ae.
argenteopunctatus, Ae. dalzieli, Ae.
furcifer, Ae. luteocephalus, Ae. taylori,
Ae. unilineatus, Ae. vittatus, An.
coustani, An. funestus, Cx. poicilipes,
Ma. uniformis
261 - -
Total 8 934
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Table 1. Cont.
Stage
Collected
Collection
SITE GPS Coordinates
Urban Rural
Sylvatic Mosquito Species
Number of
Arthropods
Screened
Virus Detected
through
Microfluidic
System
Type of
Confirmation
Performed
Larvae
Dalaba 12◦33′25.6” N/12◦10′41.0” W Rural Ae. aegypti 24 - -
Ngari 12◦38′07.3” N/12◦14′59.5” W Rural Ae. aegypti, Ae. vittatus 18 - -
Kedougou
(D1F) 12
◦36′43.9” N/12◦14′50.7” W Sylvatic
Ae. aegypti, Ae. bromeliae, Ae.
furcifer, Ae. longipalpis, Ae.
luteocephalus, Ae. taylori, Ae.
unilineatus, Ae. vittatus
237 - -
Kedougou
(E2F) 12
◦29′21.2” N/12◦06′06.2” W Sylvatic
Ae. aegypti, Ae. bromeliae, Ae.
longipalpis, Ae. luteocephalus, Ae.
neoafricanus, Ae. taylori, Ae.
unilineatus, Ae. vittatus, Er.
chrysogaster
123 - -
Total 4 402
Ae., Aedes; An., Anopheles; Cx., Culex; Er., Eretmapodites; Ma., Mansonia; YFV, Yellow fever virus. (-): no virus detected and no confirmation performed. * YFV detected in one pool of Ae.
scapularis, one pool of Ae. furcifer and confirmed in one female of this pool.
Table 2. Mosquito species, number of mosquitoes collected, and number of pools analyzed in Cambodia.
Collection
Site GPS Coordinates
Urban Rural
Sylvatic Mosquito Species
Number of
Mosquitoes
Screened
Virus Detected
through Microfluidic
System
Type of
Confirmation
Performed
Mondulkiri,
Cambodia 12
◦10′28.4”/106◦53′40.9” Sylvatic
Ae. aegypti, Ae. albopictus, Ae. gardnerri
imitator, Ae. prominens, An. barbirostris, An.
indefinitus, An. jamesii, An. kochi, An.
mimulus complex, An. philippinensis, An.
roperi, An. umbrosus, An. vegus, Ar.
annulipalpis, Ar. dolichocephalus, Ar. flavus,
Ar. foliatus/kuchingensis, Ar. moultoni, Ar.
subalbatus, Ar. theobaldi, Cx. bitaeniorhynchus,
Cx. brevipalpis, Cx. fuscocephala, Cx.
perplexus/whitei, Cx. sitiens, Cx. vishnui
complex, Hz. catesi, Hz. demeilloni
492 - -
Ae., Aedes; An., Anopheles; Ar., Armigeres; Cx., Culex; Hz., Heizmannia. (-): no virus detected and no confirmation performed.
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3.4. Endemic/Epidemic area, Brazil
In Brazil, 7705 mosquitoes (889 males and 6816 females) belonging to 22 species and 15 genera
(detailed in Table 3) were collected in 15 areas from January 2016 to May 2017. Mosquitoes were then
grouped into 647 pools and were analyzed for MBVs. In total, three different viruses (YFV, CHIKV, and
Trivittatus virus (TVTV)) were preliminary detected in six pools (in four, one, and one, respectively).
Only the presence of YFV was confirmed in the head/thorax from individual mosquitoes, from three
species (Ae. scapularis, Ae. taeniorhynchus, and Hg. leucocelaenus) by RT real-time PCR corresponding
to YFV strains currently circulating in Brazil (37). Attempts to isolate the virus were made but
remained unsuccessful.
3.5. Epidemic Areas
3.5.1. Guadeloupe
In Guadeloupe, 150 mosquito pools corresponding to 2173 mosquitoes (884 males and 1289 females)
from five species (Ae. aegypti, Culex quinquefasciatus, Anopheles albimanus, Cx. bisulcatus, Cx. nigripalpus,
54 Culex. spp.) collected from May to June 2016 were screened for 64 MBVs. ZIKV was found in two
pools of Cx. quinquefasciatus females and nine pools of Ae. aegypti (eight pools of females and one
pool of males) (Table 4). ZIKV was detected only in the head/thorax of individual Ae. aegypti females
from the eight positive pools by a RT-real-time PCR. Virus was isolated on Vero cells and full genome
sequencing identified the Asian genotype (GenBank Accession Numbers: MN185324, MN185325,
MN185327, MN185329, MN185330, MN185331, MN185332).
3.5.2. French Guiana
In French Guiana, 3942 mosquitoes (1098 males and 2844 females) from seven species (Ae. aegypti,
Ae. scapularis, Ae. taeniorhynchus, Cx. quinquefasciatus, Ma. titillans, Cq. venezualensis, and Cq. albicosta)
were collected in the Cayenne area from June to August 2016 and grouped into 248 pools to be
screened. Three pools of Ae. aegypti and one pool of Cx. quinquefasciatus were detected positive for
ZIKV (Table 5). After screening individual head/thorax from those pools, only pools of Ae. aegypti
were confirmed positive. ZIKV was isolated and fully sequenced; it belonged to the Asian genotype
(GenBank Accession numbers: MN185326 and MN185328).
3.5.3. Suriname
In Suriname, from March to May 2017, four species/genus of mosquitoes (2256 Ae. aegypti, 29 Culex
spp., 5 Haemogogus spp., 20 undetermined species) representing 2310 adults, were grouped into 77
pools and screened. No virus was detected (Table 6).
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Table 3. Mosquito species, number of mosquitoes collected, and viruses detected in Brazil.
Collection Site GPS Coordinates Urban RuralSylvatic Mosquito Species
Number of
Mosquitoes
Screened
Virus Detected
through
Microfluidic
System
Type of
Confirmation
Performed
Belo Horizonte 19◦51′59.29” S/44◦ 0′43.51” W Urban Forest Ae. albopictus, Ae. aegypti, Cx.quinquefasciatus, Sa. albiprivus 17 - -
Casimiro de Abreu 22◦26′33.31” S/42◦12′30.34” W Sylvatic Ae. scapularis 24 - -
Domingos Martins 20◦17′12.48” S/40◦50′14.35” W Sylvatic Ae. albopictus 7 - -
Goiânia 6◦40′16.32” S/49◦22′49.93” W Urban Forest
Aedeomiya, Ae. aegypti, Ae. albopictus,
Aedes sp., Coquillettidia sp., Culex sp., Hg.
leucocelaenus, Limatus sp., Mansonia sp.,
Orthopodomyia sp., Psorophora sp., Sabethes
sp., Wyeomyia sp.
689 - -
Guapimirim 22◦28′56.31” S/42◦59′26.36” W Sylvatic Ru. frontosa 10 - -
Macaé 22◦18′17.54” S/42◦ 0′8.80” W Sylvatic Ae. scapularis, Wyeomyia sp. 25 - -
Manaus 3◦00′12.78” S/59◦55′37.86” W Urban Forest
Ae. aegypti, Ae. albopictus, Aedes sp.,
Culex sp., Hg. leucocelaenus, Limatus sp.,
Orthopodomyia sp., Psorophora sp., Sabethes
sp., Trichoposopum sp., Uranotenia sp.,
Wyeomyia sp.
3939 CHIKV *
Isolation,
conventional and
real-time PCR
failed to confirm
the result
Maricá 22◦55′24.44” S/42◦42′27.88” W Sylvatic
Ae. aegypti, Ae. albopictus, Ae. scapularis,
Ae. taeniorhynchus, Culex sp., Cx.
nigripalpus, Hg. janthinomys, Hg.
leucocelaenus, Li. durhamii, Ru. humboldti
198 YFV §
YFV confirmed by
PCR
Miguel Pereira 22◦29′3.21” S/43◦18′15.98” W Sylvatic Sh. fluviatilis 12 - _
Nova Friburgo 22◦24′46.35” S/42◦18′58.57” W Sylvatic Ru. humboldti 2 CHIKV £
Isolation,
conventional and
real-time PCR
failed to confirm
the result
Queluz 22◦41′52.33” S/44◦43′43.91” W Sylvatic Wy. pilicauda, Wy. confusa 6 - -
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Table 3. Cont.
Collection Site GPS Coordinates Urban RuralSylvatic Mosquito Species
Number of
Mosquitoes
Screened
Virus Detected
through
Microfluidic
System
Type of
Confirmation
Performed
Rio de Janeiro
22◦52′45.7” S/43◦18′10.0” W Urban Ae. aegypti, Ae. albopictus, Cx.quinquefasciatus 261 - -
22◦56′6.57” S/43◦26′42.19” W Urban Forest
Ae. aegypti, Ae. albopictus, Aedes sp.,
Coquillettidia sp., Culex sp., Hg.
leucocelaenus, Mansonia sp., Psorophora sp.,
Runchomyia sp., Sabethes sp.,
Trichoposopum sp., Wyeomyia sp.
2447 TVTV $
Isolation,
conventional and
real-time PCR
failed to confirm
the result
Serra 20◦ 6′46.89” S/40◦11′12.53” W Sylvatic Ae. albopictus, Cx. quinquefasciatus 26 - -
Simonésia 19◦55′12.06” S/41◦54′20.23” W Sylvatic
Ae. albopictus, Cq. venezuelensis, Hg.
janthinomys, Hg. leucocelaenus, Sa.
albiprivus
41 - -
Teresópolis 22◦26′58.56” S/42◦59′5.43” W Sylvatic Ru. frontosa 1 - -
Total 15 7705
Ae., Aedes; Cq., Coquillettidia; Cx., Culex; Hg., Haemagogus; Li., Limatus; Ru., Runchomyia; Sa., Sabethes; Sh., Shannoniana; Wy., Wyeomyia; CHIKV, Chikungunya virus; YFV, Yellow
fever virus; TVTV, Trivittatus virus. (-): no virus detected and no confirmation performed. * CHIKV detected in one pool of Cx. erraticus; § YFV detected in one pool of Ae. scapularis, one
pool of Ae. taeniorhynchus, one pool of Hg. leucocelaenus; £ CHIKV detected in one pool of Ru. humboldti; $ TVTV detected in one pool of Cx. nigripalpus.
Table 4. Mosquito species, number of mosquitoes collected, and virus detected in Guadeloupe.
Collection Site GPS Coordinates UrbanRuralSylvatic Mosquito Species
Number of
Mosquitoes
Screened
Virus Detected
through
Microfluidic
System
Type of Confirmation Performed
Gosier 16◦ 12′ 21.229” N/61◦ 29′ 31.438” W Urban
Ae. aegypti, Cx.
quinquefasciatus, An.
albimanus
399 - -
Deshaies 16◦ 18′ 24.973” N/61◦ 47′ 39.556” W Urban/Periurban
Ae. aegypti, Cx.
quinquefasciatus, An.
albimanus, Cx. bisulcatus, De.
magnus
306 ZIKV *
Confirmed by real-time PCR on
head-thorax of individual mosquitoes,
isolation of the virus, and full genome
sequencing
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Table 4. Cont.
Collection Site GPS Coordinates UrbanRuralSylvatic Mosquito Species
Number of
Mosquitoes
Screened
Virus Detected
through
Microfluidic
System
Type of Confirmation Performed
Petit Bourg 16◦ 11′ 29.476” N/61◦ 35′ 25.753” W Urban/Periurban
Ae. aegypti, Cx.
quinquefasciatus, Cx.
nigripalpus, Culex sp.
422 ZIKV *
Confirmed by real-time PCR on
head-thorax of individual mosquitoes,
isolation of the virus, and full genome
sequencing
Le Moule 16◦ 19′ 52.342” N/61◦ 20′ 37.41” W Urban/Periurban Ae. aegypti, Cx.quinquefasciatus, Culex sp. 202 ZIKV *
Confirmed by real-time PCR on
head-thorax of individual mosquitoes,
isolation of the virus, and full genome
sequencing
Saint François 16◦ 15′ 5.141” N/61◦ 16′ 26.825” W Urban Ae. aegypti, Cx.quinquefasciatus 356 ZIKV *
Confirmed by real-time PCR on
head-thorax of individual mosquitoes,
isolation of the virus, and full genome
sequencing
Sainte Anne 16◦ 13′ 31.613” N/61◦ 23′ 9.377” W Urban/Periurban
Ae. aegypti, Cx.
quinquefasciatus, Cx.
nigripalpus, Culex sp.
325 ZIKV *
Confirmed by real-time PCR on
head-thorax of individual mosquitoes,
isolation of the virus, and full genome
sequencing
Baie Mahault 16◦ 16′ 3.979” N/61◦ 35′ 13.337” W Urban Ae. aegypti, Cx.quinquefasciatus 19 - -
Le Lamentin 16◦ 16′ 17.36” N/61◦ 37′ 59.754” W Urban/Periurban Ae. aegypti, Cx.quinquefasciatus 27 - -
Goyave 16◦ 7′ 26.447” N/61◦ 34′ 40.253” W Urban/Periurban Ae. aegypti, Cx.quinquefasciatus, Culex sp. 86 - -
Morne-à-L′eau 16◦ 19′ 53.832” N/61◦ 27′ 25.855” W Urban Ae. aegypti, Cx.quinquefasciatus 19 - -
Pointe-à-Pître 16◦ 14′ 54.499” N/61◦ 32′ 18.888” W Urban Ae. aegypti, Cx.quinquefasciatus 5 - -
Saint-Claude 16◦ 1′ 36.077” N/61◦ 42′ 6.703” W Urban/Periurban Ae. aegypti 1 - -
Petit Canal 16◦ 22′ 49.03” N/61◦ 29′ 14.384” W Urban/Periurban Culex sp. 6 - -
Total 13 2173
Ae., Aedes; An., Anopheles; Cx., Culex; De., Deinocerites. (-): no virus detected and no confirmation performed. * ZIKV detected in 2 pools of Cx. quinquefasciatus and 9 pools of Ae. aegypti, and
confirmed in 9 females Ae. aegypti (one female per pool).
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Table 5. Mosquito species, number of mosquitoes collected, and virus detected in French Guiana.
Collection Site GPS Coordinates Urban RuralSylvatic Mosquito Species
Number of
Mosquitoes
Screened
Virus Detected
through
Microfluidic
System
Type of Confirmation Performed
Cayenne 4◦55′53.08” N/52◦18′55.99” W Urban
Ae. aegypti, Ae. scapularis, Cx.
quinquefasciatus, Ma. titillans,
Cq. venezualensis, Cq. albicosta
1928 ZIKV *
Confirmed by real-time PCR on
head-thorax of individual mosquitoes,
isolation of the virus, and full genome
sequencing
Remire-Montjoly 4◦53′34.01” N/52◦16′34.32” W Urban/Periurban
Ae. aegypti, Ae. scapularis, Cx.
quinquefasciatus, Ma. titillans,
Cq. venezualensis
1078 _ -
Matoury 4◦50′52.22” N/52◦19′41.58” W Urban/Periurban
Ae. aegypti, Ae.
taeniorhynchus, Cx.
quinquefasciatus, Ma. titillans,
Cq. venezualensis, Cq. albicosta
936 ZIKV *
Confirmed by real-time PCR on
head-thorax of individual mosquitoes,
isolation of the virus, and full genome
sequencing
Total 3 3942
Ae., Aedes; Cq., Coquillettidia; Cx., Culex; Ma., Mansonia. (-): no virus detected and no confirmation performed. * ZIKV in 1 pools of Cx. quinquefasciatus and 3 pools of Ae. aegypti, and
confirmed in 3 females Ae. aegypti (one female per pool).
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Table 6. Mosquito species, number of mosquitoes collected, and virus detected in Suriname.
Collection Site GPS Urban Rural Sylvatic Mosquito Species
Number of
Mosquitoes
Screened
Virus Detected
through Microfluidic
System
Type of
Confirmation
Performed
Paramaribo 5◦51′54.2” N/55◦11′33.4” W Urban (Paramaribo) Undetermined 4 - -
Roti shop 5◦51′59.616” N/55◦6′20.952 W Urban (Paramaribo) Ae. aegypti 68 - -
Car mechanic 5◦50′35.8” N 55◦06′56.7” W Urban (Paramaribo) Ae. aegypti 96 - -
Kwikfit car mechanic 5◦50′38.1” N 55◦07′23.3” W Urban (Paramaribo) Ae. aegypti 567 - -
Family home 5◦50′33.3” N 55◦07′17.5” W Urban (Paramaribo) Ae. aegypti 296 - -
Outpatient clinic 5◦50′30.3” N/55◦7′8.615” W Urban (Paramaribo) Ae. aegypti 103 - -
Chi min restaurant 5◦49′54.408” N/55◦8′24.683 W Urban (Paramaribo) Ae. aegypti 78 - -
Albertine retirement
home 5
◦48′49.572” N/55◦11′27.6” W Urban (Paramaribo) Ae. aegypti 661 - -
Medisch
Opvoedkundig
Bureau (MOB)
5◦49′43.212” N/55◦10′41.375” W Urban (Paramaribo) Ae. aegypti 376 - -
Brownsweg 5◦0′57.384” N/55◦10′2.172” W Rural/Sylvatic Ae. aegypti, Culex sp.,Undetermined 21 - -
Brownsberg 4◦56′36.24” N/55◦10′6.6” W Rural/Sylvatic
Ae. aegypti, Culex sp.,
Haemagogus sp.,
Undetermined
40 - -
Total 11 2310
Ae., Aedes; Cx., Culex; Hg., Haemagogus. (-): no virus detected and no confirmation performed.
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4. Discussion
In this study, we developed a new high-throughput virus-detection assay based on microfluidic
PCRs able to detect 64 MBVs in mosquitoes. Only four primer sets demonstrated cross-reactivity
with viruses from the same genus or serotype. Moreover, specificity of 54 assays was not fully tested
in the absence of their respective positive controls. Nevertheless, these designs did not show any
cross-reaction with RNA positive controls from other viruses. Subsequently, we used this newly
developed assay to perform a large epidemiological survey screening in six countries/territories during
the last Zika pandemic. This new method has allowed the detection of (i) three human infecting
arboviruses, ZIKV, YFV, and CHIKV, in mosquitoes and (ii) other unexpected viruses such as TVTV.
The efficiency of our tool was the first requirement; we used artificially infected mosquitoes to
detect different viruses (DENV1-4, CHIKV, WNV, ZIKV) offered in single and dual infections. Our
assays can target DENV with however cross-reactions between serotypes. Caused by one of the four
serotypes (DENV1-4), dengue is the most important arboviral disease worldwide [14]. It is widely
accepted that a subsequent infection with a second serotype can produce more severe symptoms [15].
This situation becomes challenging when multiple serotypes co-circulate [16]. Mosquitoes co-infected
with different DENV serotypes are occasionally detected [17]. Aedes aegypti and Ae. albopictus are urban
vectors of DENV responsible for most epidemic outbreaks in Asia, Latin America, the Caribbean, and
Pacific islands [14]. Co-infected Aedes mosquitoes are capable of transmitting multiple arboviruses
during one bite [9]. Dual DENV detections in mosquitoes may be a sign of co-circulation of DENV and
then may help in predicting co-infections in humans. Diagnosis of dengue infections cannot be based
on clinical symptoms as dengue disease shares common symptoms with other arboviral diseases [18].
To discriminate dengue serotypes, viral isolation and viral RNA detection remain the gold standard
methods but should be performed during patient viremia (within five days after the onset of fever).
Less constraining and costly, mass viral screening of mosquitoes in surveillance and epidemic contexts
can be an advantageous substitute.
In the same way, WNV assays cross-reacted with the phylogenetically-related USUV. WNV is a
flavivirus responsible of neuro-invasive disease in Europe and North America [19]. Diagnosis of WNV
infection remains challenging and human cases are usually underestimated. On the other hand, USUV
has spread over Europe during the last 20 years causing bird mortalities and some rare human cases [20].
Human infections are rare and often asymptomatic, and neurological disorders can be described [20].
While WNV has circulated in Europe since the 1960s, USUV shares the same geographical distribution
and also the same vectors, Culex pipiens. Our tool did not succeed in distinguishing the two viruses,
and therefore it needs more improvements.
By screening 17,958 mosquitoes collected in six countries/territories for 64 different MBVs, we
succeeded in detecting ZIKV, YFV, CHIKV, and TVTV in mosquitoes.
The Zika outbreak was unexpected; the first human cases outside endemic regions in Africa were
reported in Yap island in 2007 where the outbreak was poorly publicized despite the two third of the
population affected [21]. Few years later, ZIKV hit French Polynesia [22] where the first notification
of severe symptoms associated to ZIKV infections were done, Guillain–Barre syndrome [23] and
microcephaly in new-born [24]. After ZIKV reached the American continent in 2015 [25], phylogenetic
analysis indicated that the circulating ZIKV belonged to the Asian clade [26,27]. Our tool was able
to detect ZIKV in pools of abdomen of Ae. aegypti and Cx. pipiens from Guadeloupe and French
Guiana. However, when analyzing disseminated viral particles in head and thorax, only Ae. aegypti
was found infected, corroborating the main role of this species in ZIKV transmission and limiting
Cx. quinquefasciatus and Cx. pipiens as a vector [28]. It is widely admitted that viral dissemination
beyond the midgut can be a clue attesting the mosquito susceptibility to a virus. However, viral
dissemination in mosquitoes depends on mosquito collection date; it increases over time after the
infectious blood meal [3]. In our study, it was not possible to have information on the physiological
age of mosquitoes and when they were infected.
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Our mass screening tool has detected YFV in five mosquito species: Aedes scapularis, Aedes
taeniorhynchus, Haemagogus janthinomys, Haemagogus leucocelaenus, and Sabethes chloropterus. The species
Hg. janthinomys and Hg. leucocelaenus are considered as the main vectors of YFV in Brazil [29,30]
while Aedes scapularis, Aedes taeniorhynchus, and Sabethes chloropterus only play a secondary role [31].
Other viruses preliminarily detected in Brazilian mosquitoes were TVTV and CHIKV. While CHIKV
continues to cause sporadic cases in Brazil after the massive outbreak in 2015, TVTV was first isolated
from Aedes trivittatus in USA in 1948, and has never been detected outside North America where
it is mainly distributed [32]. Consequences of TVTV infections on humans remain unknown [33].
Nevertheless, the presence of CHIKV and TVTV in tested mosquitoes was not confirmed.
This study demonstrates the feasibility of high-throughput screening methods to detect diverse
MBVs in field-collected mosquitoes. Performing 9216 real-time PCRs in one run took four hours, and
the cost was around $10 per reaction from sample homogenization to virus detection by real-time
PCR [10,11]. Nevertheless, the instrument is costly and requires some specific conditions of use. It is
therefore recommended to identify focal points where this technology could be developed and to
improve the conditions for transporting biological samples from the field to allow an optimal viral
screening. Another main advantage of our tool is the adaptability of the system by adding new sets of
primers and probes targeting newly emergent viruses in contrast to arrays with fixed panels of probes.
Indeed, because the number of YFV cases was unusually high since January 2016 [34], we added
specific detections of YFV strains circulating in South America to screen field-collected mosquitoes
from Brazil, French Guiana, Suriname, and Guadeloupe. In conclusion, our method designed to
specifically identify MBVs in mosquitoes can be used to screen other types of samples such as human
and/or animal blood or organs [35]. We demonstrated the usefulness of this new screening method,
which represents a powerful, cost-effective, and rapid system to track MBVs all around the world and
could be easily customized to any viral emergence.
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for full genome sequencing of Zika virus.
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